These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19169478)

  • 1. [Absence of PRKAR1A loss of heterozygosity in laser-captured microdissected pigmented nodular adrenocortical tissue from a patient with Carney complex caused by the novel nonsense mutation p.Y21X].
    Almeida MQ; Brito LP; Domenice S; Costa MH; Pinto EM; Osório CA; Latronico AC; Mendonca BB; Fragoso MC
    Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1257-63. PubMed ID: 19169478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
    Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
    Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
    Cazabat L; Ragazzon B; Groussin L; Bertherat J
    Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
    Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
    J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel splice site mutation of the PRKAR1A gene, C.440+5 G>C, in a Chinese family with Carney complex.
    Fu J; Lai F; Chen Y; Wan X; Wei G; Li Y; Xiao H; Cao X
    J Endocrinol Invest; 2018 Aug; 41(8):909-917. PubMed ID: 29318463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial isolated primary pigmented nodular adrenocortical disease associated with a novel low penetrance PRKAR1A gene splice site mutation.
    Storr HL; Metherell LA; Dias R; Savage MO; Rasmussen AK; Clark AJ; Main KM
    Horm Res Paediatr; 2010; 73(2):115-9. PubMed ID: 20190548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease and the Carney complex.
    Peck MC; Visser BC; Norton JA; Pasche L; Katznelson L
    Endocr Pract; 2010; 16(2):198-204. PubMed ID: 19833579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the M1V PRKAR1A mutation with primary pigmented nodular adrenocortical disease in two large families.
    Pereira AM; Hes FJ; Horvath A; Woortman S; Greene E; Bimpaki E; Alatsatianos A; Boikos S; Smit JW; Romijn JA; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):338-42. PubMed ID: 19915019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
    Stratakis CA
    Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
    Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenal pathophysiology: lessons from the Carney complex.
    Groussin L; Cazabat L; René-Corail F; Jullian E; Bertherat J
    Horm Res; 2005; 64(3):132-9. PubMed ID: 16192737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation.
    Takano K; Yasufuku-Takano J; Morita K; Mori S; Takei M; Osamura RY; Teramoto A; Fujita T
    Clin Endocrinol (Oxf); 2009 May; 70(5):769-75. PubMed ID: 19178533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds.
    Groussin L; Horvath A; Jullian E; Boikos S; Rene-Corail F; Lefebvre H; Cephise-Velayoudom FL; Vantyghem MC; Chanson P; Conte-Devolx B; Lucas M; Gentil A; Malchoff CD; Tissier F; Carney JA; Bertagna X; Stratakis CA; Bertherat J
    J Clin Endocrinol Metab; 2006 May; 91(5):1943-9. PubMed ID: 16464939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
    Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
    Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
    J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
    Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report of familial Carney complex due to novel frameshift mutation c.597del C (p.Phe200LeufsX6) in PRKAR1A.
    Sasaki A; Horikawa Y; Suwa T; Enya M; Kawachi S; Takeda J
    Mol Genet Metab; 2008 Nov; 95(3):182-7. PubMed ID: 18760947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro studies of novel PRKAR1A mutants that extend the predicted RIα protein sequence into the 3'-untranslated open reading frame: proteasomal degradation leads to RIα haploinsufficiency and Carney complex.
    Patronas Y; Horvath A; Greene E; Tsang K; Bimpaki E; Haran M; Nesterova M; Stratakis CA
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E496-502. PubMed ID: 22205709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.